Whalesbook
Chambal Fertilisers Sees Robust Revenue Surge Amidst Input Cost and Policy Headwinds
Chambal Fertilisers and Chemicals Limited (CFCL) has announced a strong financial performance for the third quarter and nine months ended December 31, 2025 (Q3/9M FY'26), with revenues climbing significantly year-on-year. The company reported a standalone revenue of INR 5,898 crores for Q3 FY'26, a 20% increase from the previous year, while net profit rose 12% to INR 565 crores. For the nine-month period, revenue grew by 27% to INR 18,009 crores, with net profit up 16% to INR 1,804 crores.
Financial Deep Dive
The company's performance was boosted by growth across various segments. The complex fertilizer segment saw its revenue surge by 81% year-on-year to approximately INR 1,850 crores, with sales volumes increasing to 2.94 lakh metric tons. The Crop Protection Chemicals (CPC), Specialty Nutrients, and Seed segment also showed robust growth, with revenues up 33% year-on-year to about INR 340 crores in the quarter. The biologicals portfolio demonstrated strong momentum, with volumes up 31% and revenues growing 58% year-on-year over the nine-month period.
Despite the positive top-line performance, EBITDA margins for the quarter stood at 13.92%, reflecting a 6% year-on-year increase in absolute EBITDA to INR 821 crores. The company noted a hit of INR 31 crores on account of labor codes during the quarter. Subsidy receipts for Q3 FY'26 were INR 3,880 crores, and total receivables stood at INR 2,346 crores.
Strategic Initiatives and Outlook
Chambal Fertilisers is banking on a stable outlook, with urea anchoring its volumes and cash flows, while diversification comes from DAP and NPK fertilizers. The Union Budget's allocation to the Department of Fertilizers provides long-term visibility. The company is expanding its value-added offerings with new product launches in CPC and specialty nutrients, and its biologicals portfolio is showing promising traction.
A significant development is the nearing completion of the Technical Ammonium Nitrate (TAN) project, with EPC work at 92% complete and scheduled for April 30, 2026. The total estimated cost is INR 1,645 crores. The company is also expanding capacity at its IMACID joint venture. Furthermore, a research agreement with TERI for sustainable agricultural solutions signals a move towards eco-friendly practices.
Investor Risks & Governance
However, the company faces several challenges. Discussions are ongoing with the government regarding the parameters for calculating benefits for NIP-2012 units after the policy period expires, which could positively or negatively impact estimates. Rising input costs for phosphoric acid, sulfuric acid, and ammonia are creating pricing pressures for NPK fertilizers, potentially affecting farmer affordability and offtake. Additionally, Chambal Fertilisers is managing working capital challenges arising from GST blockages. In terms of governance, while the provided information does not highlight any current major regulatory penalties or fraud allegations, a SEBI penalty of Rs 10 lakh was imposed on a director in 2018 related to Jubilant Life Sciences. The company's promoter holding increased slightly to 60.85% as of December 2025, while FII/FPI holdings saw a decrease.
Peer Comparison
Chambal Fertilisers' performance stands in contrast to some peers. For Q3 FY'26, National Fertilizers Limited (NFL) reported a substantial 203% jump in net profit to ₹93.77 crore, and Rashtriya Chemicals and Fertilizers (RCF) saw a modest 2.2% net profit rise to ₹81.37 crore. Coromandel International reported strong revenue growth of 27% for the nine months ended December 31, 2025, with net profit slightly declining for the quarter but growing significantly for the nine months. PI Industries, however, reported a weak quarter with revenue declining 28% year-on-year in Q3 FY'26. Chambal's diverse portfolio, which includes urea, complex fertilizers, and specialty chemicals, positions it differently from pure urea players like NFL and RCF. Its significant growth in complex fertilizers and CPC/specialty segments, compared to the mixed performance of peers, highlights its diversified strategy.
Detailed Crux
Chambal Fertilisers ne Q3 FY26 mein badhiya revenue growth dikhaya hai, revenue 20% badhkar ₹5,898 crore ho gaya. Profit bhi 12% badha hai. Complex fertilizers aur specialty segments mein acchi growth hui hai. Lekin, company ko input costs badhne, government ki NIP-2012 policy ke future ko lekar clarity na hone, aur GST ke karan working capital mein dikkaton ka samna karna pad raha hai. TAN project lagbhag poora hone wala hai, jo ki ek positive sign hai.
Impact (0-10): 7 - The strong revenue growth and progress on expansion projects are positive, but input cost pressures, policy uncertainty, and working capital issues pose significant risks that investors need to monitor closely.